交易中 11-16 10:09:12 美东时间
-0.600
-1.74%
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• # Lindblad Expeditions 2026财年第三季度业绩回顾摘要 ## 1. 财务业绩:**营收表现:** - 总营收达到2.692亿美元,同比增长12.1%(增加2900万美元),由探险(expedition)和陆地(land)两大板块的双位数增长共同驱动。 - Lindblad板块营收为1.534亿美元,同比增长11.5%(增加1580万美元),主要受益于入住率提升及客房单位收益增长。 - 陆地体验(Land Experiences)板块营收为1.158亿美元,同比增长12.8%(增加1320万美元),主要由12%的客流量增长带动。
11-04 12:19
Lindblad Expeditions (NASDAQ:LIND) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benz...
11-03 22:46
Lindblad Expeditions (NASDAQ:LIND) reported quarterly earnings of $0.36 per share which beat the analyst consensus estimate of $0.35 by 2.86 percent. This is a 14.29 percent decrease over earnings of $0.42 per share from the same period last year. The company reported quarterly sales of $269.151 mil...
11-03 20:31
Lindblad Expeditions (NASDAQ:LIND) raises FY2026 sales outlook from $850.000 million-$880.000 million to $870.000 million-$885.000 million vs $869.357 million estimate.
11-03 20:30
今日重点评级关注:奥本海默:维持Aurora Innovation"跑赢大市"评级,目标价从15美元升至16美元;富国银行:维持Applied Digital"超配"评级,目标价从50美元升至55美元
10-09 16:25
Jefferies analyst David Katz maintains Lindblad Expeditions (NASDAQ:LIND) with a Hold and raises the price target from $29 to $32.
10-09 04:08
Lindblad Expeditions Holdings ( ($LIND) ) just unveiled an announcement. On Sep...
09-15 20:18
Lindblad Expeditions Holdings (LIND) announced it has acquired a majority ownership of White Desert and Echo Charlie in the largest transaction in the company's history. A majority stake of 60% in Whi...
09-15 19:20
Lindblad Expeditions (NASDAQ:LIND) raises FY2026 sales outlook from $830.000 million-$860.000 million to $850.000 million-$880.000 million vs $848.983 million estimate.
09-15 19:15
今日重点评级关注:富国银行:维持Pyxis Oncology"超配"评级,目标价从12美元升至19美元;Oppenheimer:维持Opus Genetics"跑赢大市"评级,目标价从10美元升至20美元
09-10 15:00